Use access key #2 to skip to page content.
$33.97 -0.06 (-0.18%)
7/3/2008 1:00 PM

Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating:
****

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

View All Commentary (VRTX)

Recs

0

Avatar pjani06 (87.30) Submitted: 4/16/08 2:21 AM : Outperform Start Price: $25.87 VRTX Score: 36.97

In a climate where innovation has dried up, this company seems to deliver. Peers have been hit hard in this market climate however this one stood out and I believe for reason. Look for VRTX to lead long term.

Report this Post Replies: 0 | Reply

Featured Broker Partners